Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Advanced Medical Equipment & Technology - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:NSPH
- CUSIP: N/A
- Web: www.nanosphere.us/
- 50 Day Moving Avg: $1.59
- 200 Day Moving Avg: $0.95
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -2.70
- P/E Growth: 0.00
- Net Margins: -99.68%
- Return on Equity: -232.37%
- Return on Assets: -65.52%
Frequently Asked Questions for Nanosphere (NASDAQ:NSPH)
What is Nanosphere's stock symbol?
Nanosphere trades on the NASDAQ under the ticker symbol "NSPH."
How were Nanosphere's earnings last quarter?
Nanosphere, Inc. (NASDAQ:NSPH) posted its quarterly earnings results on Monday, May, 16th. The company reported ($0.55) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.59) by $0.04. The business earned $6.60 million during the quarter, compared to analyst estimates of $6.50 million. Nanosphere had a negative net margin of 99.68% and a negative return on equity of 232.37%. The company's quarterly revenue was up 43.5% on a year-over-year basis. During the same period in the previous year, the business posted ($1.29) EPS. View Nanosphere's Earnings History.
Who are some of Nanosphere's key competitors?
Some companies that are related to Nanosphere include Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Boston Scientific Corporation (BSX), Koninklijke Philips N.V. (PHG), Intuitive Surgical (ISRG), Illumina (ILMN), Edwards Lifesciences Corporation (EW), Cerner Corporation (CERN), Agilent Technologies (A), Waters Corporation (WAT), Hologic (HOLX), ResMed (RMD), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR) and Accelerate Diagnostics (AXDX).
How do I buy Nanosphere stock?
Shares of Nanosphere can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nanosphere's stock price today?
MarketBeat Community Rating for Nanosphere (NASDAQ NSPH)MarketBeat's community ratings are surveys of what our community members think about Nanosphere and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Nanosphere stock can currently be purchased for approximately $1.70.
Earnings History for Nanosphere (NASDAQ:NSPH)Earnings History by Quarter for Nanosphere (NASDAQ NSPH)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/16/2016||Q1||($0.59)||($0.55)||$6.50 million||$6.60 million||View||N/A|
|2/24/2016||Q415||($1.05)||($1.28)||$5.30 million||$6.80 million||View||Listen|
|11/9/2015||Q315||($1.15)||($1.31)||$4.89 million||$4.90 million||View||Listen|
|8/10/2015||Q215||($1.23)||($2.25)||$4.46 million||$4.72 million||View||Listen|
|5/11/2015||Q115||($1.56)||($1.29)||$4.50 million||$4.62 million||View||Listen|
|2/11/2015||Q414||($0.10)||($0.08)||$4.40 million||$4.60 million||View||Listen|
|8/6/2014||Q2||($0.12)||($0.13)||$3.90 million||$2.70 million||View||Listen|
|5/7/2014||Q1||($0.12)||($0.13)||$3.63 million||$3.28 million||View||Listen|
|5/8/2013||Q1 2013||($0.15)||($0.15)||$2.11 million||$2.40 million||View||Listen|
Earnings Estimates for Nanosphere (NASDAQ:NSPH)
Current Year EPS Consensus Estimate: $-1.65 EPS
Next Year EPS Consensus Estimate: $-0.63 EPS
Dividend History for Nanosphere (NASDAQ:NSPH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Nanosphere (NASDAQ:NSPH)Insider Trades by Quarter for Nanosphere (NASDAQ:NSPH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|5/27/2016||Mmcap International Inc. Spc||Major Shareholder||Buy||2,262,705||$1.70||$3,846,598.50|| |
|5/25/2016||Mmcap International Inc. Spc||Major Shareholder||Buy||176,781||$1.68||$296,992.08|| |
|3/28/2014||Sheli Rosenberg||Director||Buy||10,000||$2.05||$20,500.00|| |
|3/26/2014||Gene Cartwright||Director||Buy||23,200||$2.12||$49,184.00|| |
|8/22/2013||Sheli Rosenberg||Director||Buy||10,000||$2.02||$20,200.00|| |
|2/21/2013||Chad A Mirkin||Director||Buy||10,000||$1.96||$19,600.00|| |
|2/19/2013||Sheli Z Rosenberg||Director||Buy||50,000||$1.97||$98,500.00|| |
Headline Trends for Nanosphere (NASDAQ:NSPH)
Latest Headlines for Nanosphere (NASDAQ:NSPH)
Nanosphere (NSPH) Chart for Friday, July, 28, 2017